Delivery Order SPE2DB20D2104-SPE2DB25FMNZE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,940.34 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count supply) under a firm fixed price contract valued at $8,425.09. This award was competitively procured with no set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $13,864.26 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count). The contract is a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a delivery order valued at $28,136.54 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $64,313.13, with an ultimate completion date of October 21, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.51 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply). This firm fixed-price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the delivery at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count supply) valued at $6,315.18 under a firm fixed-price contract type. This award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $5,646.47. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,550.59 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units), with an ultimate completion date of July 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMNZEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (30-count units) valued at $7,441.72. This is a firm fixed-price, non-set-aside contract with a completion deadline of August 7, 2025, and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through competitive awards positions it as a primary supplier within the DLA Medical Supply Chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 8/6/25 |